Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3542)
All Articles published online
|
Aug 14, 2005 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yuan SF, Li KZ, Wang L, Dou KF, Yan Z, Han W, Zhang YQ. Expression of MUC1 and its significance in hepatocellular and cholangiocarcinoma tissue. World J Gastroenterol 2005; 11(30): 4661-4666 [PMID: 16094706 DOI: 10.3748/wjg.v11.i30.4661] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i30/4661.htm |
| Number | Citing Articles |
| 1 |
Qiongshu Li, Guomu Liu, Hongyan Yuan, Juan Wang, Yingying Guo, Tanxiu Chen, Ruiping Zhai, Dan Shao, Weihua Ni, Guixiang Tai. Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21WAF1 pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells. Oncotarget 2015; 6(6): 4253 doi: 10.18632/oncotarget.2973
|
| 2 |
Anne Demols, Raphaël Maréchal, Jacques Devière, Jean-Luc Van Laethem. Biliary tract cancers: From pathogenesis to endoscopic treatment. Best Practice & Research Clinical Gastroenterology 2007; 21(6): 1015 doi: 10.1016/j.bpg.2007.09.005
|
| 3 |
Dan Li, Shaoli Lin, Jessica Hong, Mitchell Ho. Hepatobiliary Cancers: Translational Advances and Molecular Medicine. Advances in Cancer Research 2022; 156: 415 doi: 10.1016/bs.acr.2022.01.013
|
| 4 |
|
| 5 |
Aldona Kasprzak, Agnieszka Adamek. Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis. International Journal of Molecular Sciences 2019; 20(6): 1288 doi: 10.3390/ijms20061288
|
| 6 |
Shailendra K. Gautam, Parvez Khan, Gopalakrishnan Natarajan, Pranita Atri, Abhijit Aithal, Apar K. Ganti, Surinder K. Batra, Mohd W. Nasser, Maneesh Jain. Mucins as Potential Biomarkers for Early Detection of Cancer. Cancers 2023; 15(6): 1640 doi: 10.3390/cancers15061640
|
| 7 |
|
| 8 |
Watcharin Loilome, Hasaya Dokduang, Manida Suksawat, Sureerat Padthaisong. Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma. Expert Opinion on Investigational Drugs 2021; 30(9): 985 doi: 10.1080/13543784.2021.1955102
|
| 9 |
Keyur Patel, Ryan Lamm, Peter Altshuler, Hien Dang, Ashesh P. Shah. Hepatocellular Carcinoma—The Influence of Immunoanatomy and the Role of Immunotherapy. International Journal of Molecular Sciences 2020; 21(18): 6757 doi: 10.3390/ijms21186757
|
| 10 |
Mohammad Heiat, Hamid Hashemi Yeganeh, Seyed Moayed Alavian, Ehsan Rezaie. Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising Prospect. Toxins 2021; 13(10): 719 doi: 10.3390/toxins13100719
|
| 11 |
Monica Mossenta, Davide Busato, Michele Dal Bo, Paolo Macor, Giuseppe Toffoli. Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies. International Journal of Molecular Sciences 2022; 23(17): 10038 doi: 10.3390/ijms231710038
|
| 12 |
AM Attallah, M El-Far, AR Ibrahim, MA El-desouky, MM Omran, MS Elbendary, KA Attallah, ER Qura, SO Abdallah. Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1. British Journal of Biomedical Science 2018; 75(3): 122 doi: 10.1080/09674845.2018.1456309
|
| 13 |
Ming Xu, Yang Pan. Chimeric Antigen Receptor (CAR)‐T Cells: A New Era for Hepatocellular Carcinoma Treatment. Journal of Biochemical and Molecular Toxicology 2024; 38(12) doi: 10.1002/jbt.70091
|
| 14 |
Ayana R. Kumar, Aswathy R. Devan, Bhagyalakshmi Nair, Reshma Ravindran Nair, Lekshmi R. Nath. Biology, Significance and Immune Signaling of Mucin 1 in Hepatocellular Carcinoma. Current Cancer Drug Targets 2022; 22(9): 725 doi: 10.2174/1568009622666220317090552
|
| 15 |
Ragini Singh, Ayush Sharma, Joel Saji, Akhela Umapathi, Santosh Kumar, Hemant Kumar Daima. Smart nanomaterials for cancer diagnosis and treatment. Nano Convergence 2022; 9(1) doi: 10.1186/s40580-022-00313-x
|
| 16 |
Kurinchi Gurusamy. Trace Element Concentration in Primary Liver Cancers—A Systematic Review. Biological Trace Element Research 2007; 118(3): 191 doi: 10.1007/s12011-007-0008-x
|
| 17 |
Abdelfattah M. Attallah, Mohamed El-Far, Sanaa O. Abdallah, Ahmed M. El-Waseef, Mohamed M. Omran, Mohamed A. Abdelrazek, Ahmed A. Attallah, Mohamed J. Saadh, Mohamed Radwan, Kholoud A. El-waffaey, Hassan Abol-Enei. Combined use of Epithelial Membrane Antigen and Nuclear Matrix Protein 52 as Sensitive Biomarkers for Detection of Bladder Cancer. The International Journal of Biological Markers 2015; 30(4): 407 doi: 10.5301/jbm.5000164
|
| 18 |
Harriet Roddy, Tim Meyer, Claire Roddie. Novel Cellular Therapies for Hepatocellular Carcinoma. Cancers 2022; 14(3): 504 doi: 10.3390/cancers14030504
|
| 19 |
QIONGSHU LI, FENGLI WANG, GUOMU LIU, HONGYAN YUAN, TANXIU CHEN, JUAN WANG, FEI XIE, RUIPING ZHAI, FANG WANG, YINGYING GUO, WEIHUA NI, GUIXIANG TAI. Impact of Mucin1 knockdown on the phenotypic characteristics of the human hepatocellular carcinoma cell line SMMC-7721. Oncology Reports 2014; 31(6): 2811 doi: 10.3892/or.2014.3136
|
| 20 |
Zhixiong Cai, Yongyi Zeng, Bo Xu, Yunzhen Gao, Sen Wang, Jinhua Zeng, Lihong Chen, Aimin Huang, Xiaolong Liu, Jingfeng Liu. Galectin‐4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma. Cancer Science 2014; 105(11): 1510 doi: 10.1111/cas.12536
|
| 21 |
Kamonlapat Supimon, Thanich Sangsuwannukul, Jatuporn Sujjitjoon, Nattaporn Phanthaphol, Thaweesak Chieochansin, Naravat Poungvarin, Sopit Wongkham, Mutita Junking, Pa-thai Yenchitsomanus. Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85747-9
|
| 22 |
J. Y. H. Chan, K. K. H. Lee, Y. L. Chui. Hilar Cholangiocarcinoma. 2013; : 111 doi: 10.1007/978-94-007-6473-6_10
|
| 23 |
Anjana Menon, Ayana R. Kumar, Mahima Bharathi, Adithya Jayaprakash Kamath, Asawari Dilip Donadkar, M. S. Sudheesh, Lekshmi R. Nath. Nanotechnology Based Strategies for Cancer Immunotherapy. 2024; : 249 doi: 10.1007/978-981-97-7022-9_9
|
| 24 |
O. E. Kuznetsov, V. M. Tsyrkunov, S. Sh. Kerimova. Mucin expression in liver cancer. Doklady of the National Academy of Sciences of Belarus 2023; 67(1): 59 doi: 10.29235/1561-8323-2023-67-1-59-65
|
| 25 |
Giray Bozkaya, Peyda Korhan, Murat Çokaklı, Esra Erdal, Özgül Sağol, Sedat Karademir, Christopher Korch, Neşe Atabey. Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis. Molecular Cancer 2012; 11(1) doi: 10.1186/1476-4598-11-64
|
| 26 |
Qiongshu Li, Guomu Liu, Dan Shao, Juan Wang, Hongyan Yuan, Tanxiu Chen, Ruiping Zhai, Weihua Ni, Guixiang Tai. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells. The International Journal of Biochemistry & Cell Biology 2015; 59: 116 doi: 10.1016/j.biocel.2014.11.012
|
| 27 |
Pengfei Hao, Qi Li, Haoliang Zhao. Mucin 1 expression is regulated by hsa_circ_0055054/microRNA‑122‑5p and promotes hepatocellular carcinoma development. Oncology Letters 2024; 28(3) doi: 10.3892/ol.2024.14537
|
| 28 |
Xueyin Zhou, Bin Zhang, Jiahao Hu, Jiliang Shen, Zhehan Chen, Jinming Zhang, Bowen Wu, Enjie Zhou, Shuyou Peng, Tuck-Whye Wong, Guanjun Yang, Jiasheng Cao, Mingyu Chen. Igniting cold tumors of intrahepatic cholangiocarcinoma: An insight into immune evasion and tumor immune microenvironment. The Innovation Medicine 2024; 2(1): 100052 doi: 10.59717/j.xinn-med.2024.100052
|
| 29 |
Xinyu Shao. Immune microenvironment and progress in immunotherapy of cholangiocarcinoma. Clinical Immunology Communications 2023; 4: 73 doi: 10.1016/j.clicom.2023.11.002
|
| 30 |
Abdelfattah M. Attallah, Sanaa O. Abdallah, Amr S. El Sayed, Mohamed M. Omran, Mahmoud El‐Bendary, Khaled Farid, Mohamed Kadry. Non‐invasive predictive score of fibrosis stages in chronic hepatitis C patients based on epithelial membrane antigen in the blood in combination with routine laboratory markers. Hepatology Research 2011; 41(11): 1075 doi: 10.1111/j.1872-034X.2011.00862.x
|
| 31 |
HONGYAN YUAN, JUAN WANG, FENGLI WANG, NANNAN ZHANG, QIONGSHU LI, FEI XIE, TANXIU CHEN, RUIPING ZHAI, FANG WANG, YINGYING GUO, WEIHUA NI, GUIXIANG TAI. Mucin 1 gene silencing inhibits the growth of SMMC-7721 human hepatoma cells through Bax-mediated mitochondrial and caspase-8-mediated death receptor apoptotic pathways. Molecular Medicine Reports 2015; 12(5): 6782 doi: 10.3892/mmr.2015.4323
|
| 32 |
Parnaz Merikhian, Reyhane Ghadirian, Leila Farahmand, Sepideh Mansouri, Keivan Majidzadeh-A. MUC1 induces tamoxifen resistance in estrogen receptor-positive breast cancer. Expert Review of Anticancer Therapy 2017; 17(7): 607 doi: 10.1080/14737140.2017.1340837
|
| 33 |
Neda Dadgar, Arun K. Arunachalam, Hanna Hong, Yee Peng Phoon, Jorge E. Arpi-Palacios, Melis Uysal, Chase J. Wehrle, Federico Aucejo, Wen Wee Ma, Jan Joseph Melenhorst. Advancing Cholangiocarcinoma Care: Insights and Innovations in T Cell Therapy. Cancers 2024; 16(18): 3232 doi: 10.3390/cancers16183232
|
| 34 |
Xiaoting Luo, Xin He, Xingmei Zhang, Xiaohui Zhao, Yuzhe Zhang, Yusheng Shi, Shengni Hua. Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy. MedComm 2024; 5(2) doi: 10.1002/mco2.474
|
| 35 |
IpekIsik Gonul, Asli Cakir, Sinan Sozen. Immunohistochemical expression profiles of MUC1 and MUC2 mucins in urothelial tumors of bladder. Indian Journal of Pathology and Microbiology 2018; 61(3): 350 doi: 10.4103/IJPM.IJPM_12_18
|
| 36 |
Nicholas M. Riley, Ru M. Wen, Carolyn R. Bertozzi, James D. Brooks, Sharon J. Pitteri. Novel Methods and Pathways in Cancer Glycobiology Research. Advances in Cancer Research 2023; 157: 83 doi: 10.1016/bs.acr.2022.09.001
|
| 37 |
Thomas T DeLeon, Yumei Zhou, Bolni M Nagalo, Raquel T Yokoda, Daniel H Ahn, Ramesh K Ramanathan, Marcela A Salomao, Bashar A Aqel, Amit Mahipal, Tanios S Bekaii-Saab, Mitesh J Borad. Novel Immunotherapy Strategies for Hepatobiliary Cancers. Immunotherapy 2018; 10(12): 1077 doi: 10.2217/imt-2018-0024
|
| 38 |
Chameli Ratan, Dalia Cicily K. D, Bhagyalakshmi Nair, Lekshmi. R. Nath. MUC Glycoproteins: Potential Biomarkers and Molecular Targets for Cancer Therapy. Current Cancer Drug Targets 2021; 21(2): 132 doi: 10.2174/1568009620666201116113334
|
| 39 |
Zixing Wang, Wenlong Xu, Haifeng Zhu, Yin Liu. A Bayesian Framework to Improve MicroRNA Target Prediction by Incorporating External Information. Cancer Informatics 2014; : CIN.S16348 doi: 10.4137/CIN.S16348
|
| 40 |
Christopher D. Briggs, Christopher P. Neal, Christopher D. Mann, William P. Steward, Margaret M. Manson, David P. Berry. Prognostic molecular markers in cholangiocarcinoma: A systematic review. European Journal of Cancer 2009; 45(1): 33 doi: 10.1016/j.ejca.2008.08.024
|
| 41 |
Abdelfattah M. Attallah, Mohamed El-Far, Camelia A. Abdel Malak, Mohamed M. Omran, Khaled Farid, Raida S. Yahya, Entsar A. Saad, Mohamed S. Albannan, Ahmed A. Attallah, Mohamed A. El Basuni, Islam S. Ali, Safaa B. Abed, Mohamed A. El Naggar. A simple diagnostic index comprising epithelial membrane antigen and fibronectin for hepatocellular carcinoma. Annals of Hepatology 2015; 14(6): 869 doi: 10.5604/16652681.1171774
|
| 42 |
Davide Busato, Monica Mossenta, Lorena Baboci, Federica Di Cintio, Giuseppe Toffoli, Michele Dal Bo. Novel immunotherapeutic approaches for hepatocellular carcinoma treatment. Expert Review of Clinical Pharmacology 2019; 12(5): 453 doi: 10.1080/17512433.2019.1598859
|
| 43 |
Zhang Guizhen, Ji Guanchang, Liu Liwen, Wang Huifen, Ren Zhigang, Sun Ranran, Yu Zujiang. The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.918869
|
| 44 |
Gi Jeong Kim, Hyungjin Rhee, Jeong Eun Yoo, Jung Eun Ko, Jee San Lee, Hyunki Kim, Jin Sub Choi, Young Nyun Park, Philip C. Trackman. Increased Expression of CCN2, Epithelial Membrane Antigen, and Fibroblast Activation Protein in Hepatocellular Carcinoma with Fibrous Stroma Showing Aggressive Behavior. PLoS ONE 2014; 9(8): e105094 doi: 10.1371/journal.pone.0105094
|
| 45 |
Kamonlapat Supimon, Thanich Sangsuwannukul, Jatuporn Sujjitjoon, Thaweesak Chieochansin, Mutita Junking, Pa-thai Yenchitsomanus. Cytotoxic activity of anti-mucin 1 chimeric antigen receptor T cells expressing PD-1-CD28 switch receptor against cholangiocarcinoma cells. Cytotherapy 2023; 25(2): 148 doi: 10.1016/j.jcyt.2022.10.006
|
| 46 |
Harmeet Malhi, Gregory J. Gores. Cholangiocarcinoma: Modern advances in understanding a deadly old disease. Journal of Hepatology 2006; 45(6): 856 doi: 10.1016/j.jhep.2006.09.001
|